Home/Kira Pharmaceuticals/Wenru Song

WS

Wenru Song

President & Head of R&D, Co-founder

Kira Pharmaceuticals

Therapeutic Areas

Hematology Nephrology Neurology Dermatology Ophthalmology

Kira Pharmaceuticals Pipeline

Drug	Indication	Phase
KP104	Paroxysmal Nocturnal Hemoglobinuria (PNH)	Phase 2

Leadership Team at Kira Pharmaceuticals

Frederick Beddingfield

Chief Executive Officer

View full Kira Pharmaceuticals profile